{"api":"v1","generated_at":"2026-10-01T10:20:09.331Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-periop-doac-2d785a","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-periop-doac-2d785a/at/2026-10-01T05-50Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-10-01T05:50:06.230Z","snapshot_stamp":"2026-10-01T05-50Z","endpoint":{"slug":"api-magentlab-com-api-calc-periop-doac-2d785a","canonical_url":"https://api.magentlab.com/api/calc/periop_doac","resource":"https://api.magentlab.com/api/calc/periop_doac","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"Douketis 2022 ACCP elective perioperative DOAC interruption (PAUSE-style, recommendations 22-25). Returns hold_days_before and resume_days_after from INN (apixaban, rivaroxaban, edoxaban, dabigatran) and bleed_risk. dabigatran also needs caller-assigned CrCl. heparin_bridge is always false (recommendation 26). Not warfarin, not urgent surgery, not a prescription. magent does not assay CrCl.","service_name":"magent","declared_category":null,"declared_tags":["periop-doac","doac","hematology","perioperative","anticoagulation"],"route_template":null,"registry_updated":"2026-09-28T15:15:51.960Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc periop doac","category":"search","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-10-01T05:50:06.230Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-10-01T05:50:06.230Z","calls_30d":2,"unique_payers_30d":1,"last_called_at":"2026-09-28T15:15:51.824Z"},"validation":{"latest":{"observed_at":"2026-10-01T06:57:16.652Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-10-01"},"uptime":[{"days":7,"observed":5,"passed":5,"ratio":1},{"days":30,"observed":5,"passed":5,"ratio":1},{"days":90,"observed":5,"passed":5,"ratio":1}],"history_90d":[{"observed_at":"2026-10-01T06:57:16.652Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-01","state_changed":false},{"observed_at":"2026-09-30T06:14:19.015Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T18:34:56.746Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T16:54:07.521Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-28","state_changed":false},{"observed_at":"2026-09-28T16:40:03.580Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["periop-doac","doac","hematology","perioperative","anticoagulation"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/periop_doac","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T15:15:51.824Z","l30DaysTotalCalls":2,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/periop_doac","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"doac":"apixaban","bleed_risk":"low_to_moderate","crcl_ml_min":40},{"doac":"apixaban","bleed_risk":"low_to_moderate","crcl_ml_min":40}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/periop_doac","count":2,"items":[{"doac":"apixaban","formula":"periop_doac","citation":{"id":"douketis-2022","doi":"10.1016/j.chest.2022.07.025","pmid":"35964704","title":"Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline","source":"Chest. 2022;162(5):e207-e243","authors":"Douketis JD, Spyropoulos AC, Murad MH, et al."},"criteria":[{"met":true,"value":"apixaban","factor":"doac"},{"met":false,"value":"low_to_moderate","factor":"high_bleed_risk"},{"met":false,"factor":"dabigatran"},{"met":false,"factor":"dabigatran_crcl_lt_50"}],"bleed_risk":"low_to_moderate","disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","heparin_bridge":false,"hold_days_before":1,"resume_days_after":1,"formula_expression":"Douketis 2022 PAUSE-style elective DOAC interruption (recommendations 22-25): apixaban/rivaroxaban/edoxaban hold 1 day (low_to_moderate) or 2 days (high); dabigatran CrCl>=50 same 1/2; dabigatran CrCl<50 hold 2 (low_to_moderate) or 4 (high); resume 1 day after low_to_moderate or 2 days after high; heparin_bridge always false (recommendation 26)","total_pre_post_days":2},{"doac":"apixaban","formula":"periop_doac","citation":{"id":"douketis-2022","doi":"10.1016/j.chest.2022.07.025","pmid":"35964704","title":"Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline","source":"Chest. 2022;162(5):e207-e243","authors":"Douketis JD, Spyropoulos AC, Murad MH, et al."},"criteria":[{"met":true,"value":"apixaban","factor":"doac"},{"met":false,"value":"low_to_moderate","factor":"high_bleed_risk"},{"met":false,"factor":"dabigatran"},{"met":false,"factor":"dabigatran_crcl_lt_50"}],"bleed_risk":"low_to_moderate","disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","heparin_bridge":false,"hold_days_before":1,"resume_days_after":1,"formula_expression":"Douketis 2022 PAUSE-style elective DOAC interruption (recommendations 22-25): apixaban/rivaroxaban/edoxaban hold 1 day (low_to_moderate) or 2 days (high); dabigatran CrCl>=50 same 1/2; dabigatran CrCl<50 hold 2 (low_to_moderate) or 4 (high); resume 1 day after low_to_moderate or 2 days after high; heparin_bridge always false (recommendation 26)","total_pre_post_days":2}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["doac","bleed_risk"],"properties":{"doac":{"enum":["apixaban","rivaroxaban","edoxaban","dabigatran"],"type":"string","description":"Direct oral anticoagulant INN, case-insensitive: apixaban, rivaroxaban, edoxaban, or dabigatran. Elective procedures only. Not warfarin or a VKA."},"bleed_risk":{"enum":["low_to_moderate","high"],"type":"string","description":"Procedure bleed-risk category from Douketis 2022, case-insensitive: low_to_moderate or high. Caller assigns the category. Not urgent surgery."},"crcl_ml_min":{"type":"number","description":"Caller-assigned creatinine clearance in mL/min (15-120). Required only when doac is dabigatran. Must be absent for apixaban, rivaroxaban, and edoxaban. magent does not assay CrCl."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"Douketis 2022 ACCP elective perioperative DOAC interruption (PAUSE-style, recommendations 22-25). Returns hold_days_before and resume_days_after from INN (apixaban, rivaroxaban, edoxaban, dabigatran) and bleed_risk. dabigatran also needs caller-assigned CrCl. heparin_bridge is always false (recommendation 26). Not warfarin, not urgent surgery, not a prescription. magent does not assay CrCl.","lastUpdated":"2026-09-28T15:15:51.96Z","serviceName":"magent","x402Version":2}]}}